BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gelu-Simeon M, Burlaud A, Young J, Pelletier G, Buffet C. Evolution and predictive factors of thyroid disorder due to interferon alpha in the treatment of hepatitis C. World J Gastroenterol 2009; 15(3): 328-333 [PMID: 19140232 DOI: 10.3748/wjg.15.328]
URL: https://www.wjgnet.com/1007-9327/full/v15/i3/328.htm
Number Citing Articles
1
Zehui Yan, Ke Fan, Yi Fan, Xiaohong Wang, Qing Mao, Guohong Deng, Yuming Wang. Thyroid Dysfunction in Chinese Patients with Chronic Hepatitis C Treated with Interferon Alpha: Incidence, Long-Term Outcome and Predictive FactorsHepatitis Monthly 2012; 12(9) doi: 10.5812/hepatmon.6390
2
J.-G. Marchand, G. Russ, E. Ghanassia, J. Tramalloni, H. Monpeyssen, P.-Y. Marcy. Imagerie des dysthyroïdiesJournal d'imagerie diagnostique et interventionnelle 2022; 5(3): 141 doi: 10.1016/j.jidi.2021.12.006
3
Jennifer S. Mammen, Sharon R. Ghazarian, Erik Pulkstenis, G. Mani Subramanian, Antony Rosen, Paul W. Ladenson. Phenotypes of Interferon-α-Induced Thyroid Dysfunction among Patients Treated for Hepatitis C Are Associated with Pretreatment Serum TSH and Female SexThe Journal of Clinical Endocrinology & Metabolism 2012; 97(9): 3270 doi: 10.1210/jc.2012-1026
4
Jennifer S. Mammen, Sharon R. Ghazarian, Antony Rosen, Paul W. Ladenson. Patterns of Interferon-Alpha–Induced Thyroid Dysfunction Vary with Ethnicity, Sex, Smoking Status, and Pretreatment Thyrotropin in an International Cohort of Patients Treated for Hepatitis CThyroid 2013; 23(9): 1151 doi: 10.1089/thy.2012.0565
5
Linghuan Wang, Binqi Li, He Zhao, Peixin Wu, Qingzhen Wu, Kang Chen, Yiming Mu. A systematic review and meta-analysis of endocrine-related adverse events associated with interferonFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.949003
6
Seán J. Costelloe, Nancy Wassef, Josephine Schulz, Tina Vaghijiani, Catherine Morris, Stephen Whiting, Michael Thomas, Geoffrey Dusheiko, Michael Jacobs, Mark P. J. Vanderpump. Thyroid dysfunction in a UK hepatitis C population treated with interferon‐α and ribavirin combination therapyClinical Endocrinology 2010; 73(2): 249 doi: 10.1111/j.1365-2265.2010.03785.x
7
Huy A. Tran, Tracey L. Jones, Elizabeth A. Ianna, Aidan Foy, Glenn E.M. Reeves. Thyroid Disease in Chronic Hepatitis C Infection Treated With Combination Interferon-a and Ribavirin: Management Strategies and Future PerspectiveEndocrine Practice 2013; 19(2): 292 doi: 10.4158/EP12195.RA
8
Hai Fang, Julian Gough. A disease-drug-phenotype matrix inferred by walking on a functional domain networkMolecular BioSystems 2013; 9(7): 1686 doi: 10.1039/c3mb25495j
9
Ren-Wen Zhang, Cui-Ping Shao, Na Huo, Min-Ran Li, Hong-Li Xi, Min Yu, Xiao-Yuan Xu. Thyroid dysfunction in Chinese hepatitis C patients: Prevalence and correlation with TPOAb and CXCL10World Journal of Gastroenterology 2015; 21(33): 9765-9773 doi: 10.3748/wjg.v21.i33.9765
10
Shigeki Morita, Takuya Honda, Fumihiro Mawatari, Shotaro Tsuruta, Ryuji Furukawa. A case of Graves' disease following painless thyroiditis induced by pegylated-interferon and ribavirin therapy to a patient with chronic hepatitis CKanzo 2010; 51(6): 300 doi: 10.2957/kanzo.51.300
11
Frederik A. Verburg, Markus Luster, Cristina Cupini, Luca Chiovato, Leonidas Duntas, Rossella Elisei, Ulla Feldt-Rasmussen, Harald Rimmele, Ettore Seregni, Johannes W.A. Smit, Christian Theimer, Luca Giovanella. Implications of Thyroglobulin Antibody Positivity in Patients with Differentiated Thyroid Cancer: A Clinical Position StatementThyroid 2013; 23(10): 1211 doi: 10.1089/thy.2012.0606
12
Jean P. Molleston, William Mellman, Michael R. Narkewicz, William F. Balistreri, Regino P. Gonzalez‐Peralta, Maureen M. Jonas, Steven J. Lobritto, Parvathi Mohan, Karen F. Murray, Dolores Njoku, Philip Rosenthal, Bruce A. Barton, Monica V. Talor, Irene Cheng, Kathleen B. Schwarz, Barbara A. Haber. Autoantibodies and Autoimmune Disease During Treatment of Children With Chronic Hepatitis CJournal of Pediatric Gastroenterology and Nutrition 2013; 56(3): 304 doi: 10.1097/MPG.0b013e3182774cae
13
Amina Nadeem, Muhammad Aslam. Association of Interferon-Alpha and Ribavirin-Induced Thyroid Dysfunction with Severity of Disease and Response to Treatment in Pakistani Asian Patients of Chronic Hepatitis CHepatitis Research and Treatment 2012; 2012: 1 doi: 10.1155/2012/864315
14
Current World LiteratureCurrent Opinion in Endocrinology, Diabetes & Obesity 2009; 16(5): 401 doi: 10.1097/MED.0b013e32833118e2
15
Wenxue Zhao, Fanpu Ji, Shanshan Yu, Zongfang Li, Hong Deng. Dilated cardiomyopathy and hypothyroidism associated with pegylated interferon and ribavirin treatment for chronic hepatitis C: case report and literature reviewThe Brazilian Journal of Infectious Diseases 2014; 18(1): 110 doi: 10.1016/j.bjid.2013.05.014
16
Braira Wahid, Muhammad Waqar, Nouman Rasool, Muhammad Wasim, Ifrah Khalid, Muhammad Idrees. Prevalence of thyroid stimulating hormone dysfunction among sofosbuvir‐treated HCV‐infected patients: A real‐world clinical experienceJournal of Medical Virology 2019; 91(3): 514 doi: 10.1002/jmv.25319
17
Huy A. Tran, Glenn E. M. Reeves, Paul M. Yen. The Spectrum of Autoimmune Thyroid Disease in the Short to Medium Term Following Interferon‐α Therapy for Chronic Hepatitis CInternational Journal of Endocrinology 2009; 2009(1) doi: 10.1155/2009/241786
18
Debora Lucia Seguro Danilovic, Maria Cassia Mendes-Correa, Maria Cristina Chammas, Heverton Zambrini, Suemi Marui. Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirinClinics 2011; 66(10): 1757 doi: 10.1590/S1807-59322011001000014